| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/21/2002 | CA2685447A1 Pharmaceutical composition |
| 02/21/2002 | CA2458275A1 Novel pseudoerythromycin derivatives |
| 02/21/2002 | CA2431954A1 A retroviral immunotherapy |
| 02/21/2002 | CA2423337A1 Methods for treating subjects infected with a herpes virus orneisseria gonorrheae |
| 02/21/2002 | CA2419985A1 Modulating multiple lineage kinase proteins |
| 02/21/2002 | CA2419855A1 Stimulating neutrophil function to treat inflammatory bowel disease |
| 02/21/2002 | CA2419790A1 System for regulating in vivo the expression of a transgene by conditional inhibition |
| 02/21/2002 | CA2419716A1 Plant-derived and synthetic phenolic compounds and plant extracts, effective in the treatment and prevention of chlamydial infections |
| 02/21/2002 | CA2419550A1 Substituted pyrazoles |
| 02/21/2002 | CA2419540A1 Substituted pyrazoles |
| 02/21/2002 | CA2419418A1 Vaccines containing ribavirin and methods of use thereof |
| 02/21/2002 | CA2419414A1 Use of triazinetrione sulfoxides for controlling coccidioses |
| 02/21/2002 | CA2419406A1 Pharmaceutical combinations of torcetrapib and atorvastatin or hydroxy derivatives for the treatment of atherosclerosis, angina and low hdl levels |
| 02/21/2002 | CA2419405A1 Steroid hormones as transfer agents |
| 02/21/2002 | CA2419181A1 Processes for preparing cilostazol |
| 02/21/2002 | CA2419158A1 Method for the prevention and treatment of retinopathy |
| 02/21/2002 | CA2419081A1 Micronized torsemide |
| 02/21/2002 | CA2419073A1 Novel alicyclic imidazoles as h3 agents |
| 02/21/2002 | CA2419047A1 Water-soluble prodrugs of propofol for treatment of migraine |
| 02/21/2002 | CA2419033A1 Treatment of the insulin resistance syndrome with selective cgmp pde5 inhibitors |
| 02/21/2002 | CA2419020A1 Pyruvate:nadp+ oxidoreductase and uses thereof |
| 02/21/2002 | CA2418988A1 Treatment of tumors with acetylenes distributed with a phenyl or heteroaromatic group and a substituted chromanyl, thiochromanyl or tetrahydroquinolinyl group in combination with other anti-tumor agents |
| 02/21/2002 | CA2418853A1 2,4-substituted pyridine derivatives |
| 02/21/2002 | CA2418455A1 Valproic acid derivatives for the treatment of pain |
| 02/21/2002 | CA2418389A1 Pyridine derivatives as inhibitors of p38 |
| 02/21/2002 | CA2418273A1 Urea compounds and methods of uses |
| 02/21/2002 | CA2417918A1 Compositions containing an inhibitor of dihydrofolate reductase and a folate |
| 02/21/2002 | CA2417846A1 2-aminopyridine compounds and medical use thereof |
| 02/21/2002 | CA2417821A1 Process for the preparation of imidazopyridines |
| 02/21/2002 | CA2417807A1 Process for the preparation of dinapsoline |
| 02/21/2002 | CA2417129A1 Obesity controlling method |
| 02/21/2002 | CA2416440A1 Compositions and methods for inhibiting islet dysfunction and autoimmune disorders |
| 02/21/2002 | CA2413762A1 Compounds for the treatment of addictive disorders |
| 02/21/2002 | CA2387548A1 Bioavailable composition of natural and synthetic hca |
| 02/21/2002 | CA2386985A1 Compositions and methods for inhibiting islet dysfunction and autoimmune disorders |
| 02/20/2002 | EP1180686A1 Remedies for kidney diseases and method for screening the same |
| 02/20/2002 | EP1180520A1 Heterocyclic carboxylic acid derivatives |
| 02/20/2002 | EP1180519A1 Hydrochloride of fused-heterocycle compound |
| 02/20/2002 | EP1180518A1 5-pyridyl-1,3-azole compounds, process for producing the same and use thereof |
| 02/20/2002 | EP1180371A1 Agents promoting the formation of skin basement membrane, agents promoting the formation of artificial skin and process for producing artificial skin |
| 02/20/2002 | EP1180369A1 MEDICINAL COMPOSITIONS CONTAINING ANTI-Fas ANTIBODY |
| 02/20/2002 | EP1180367A1 Intestinal fermentation sulfide deodorizers |
| 02/20/2002 | EP1180366A1 Neuronal death inhibitors |
| 02/20/2002 | EP1180364A1 Steroid hormones as transfer agents |
| 02/20/2002 | EP1180331A1 Blends of isoflavones and flavones |
| 02/20/2002 | EP1180239A2 Methods, pharmaceutical formulations and kits for identification of subjects at risk for cancer |
| 02/20/2002 | EP1180151A2 Protein kinases |
| 02/20/2002 | EP1180143A2 Methods of inducing regulated pancreatic hormone production in non-pancreatic islet tissues |
| 02/20/2002 | EP1180141A2 The p2x 3 receptor, methods of altering p2x 3receptor activity and uses thereof |
| 02/20/2002 | EP1180120A2 Variant of the plasmodium merozoite surface protein (msp-1) and vaccine comprising said variant |
| 02/20/2002 | EP1180118A1 Fimbrial proteins |
| 02/20/2002 | EP1180116A2 Fap-activated anti-tumor compounds |
| 02/20/2002 | EP1180110A1 13-methyl-erythromycin derivatives |
| 02/20/2002 | EP1180109A1 Prodrug activation using catalytic antibodies |
| 02/20/2002 | EP1180105A2 Substituted aza-oxindole derivatives |
| 02/20/2002 | EP1180103A1 Renin inhibitors |
| 02/20/2002 | EP1180102A1 Mutual prodrugs of amlodipine and atorvastatin |
| 02/20/2002 | EP1180101A1 Compounds having cytokine inhibitory activity |
| 02/20/2002 | EP1180100A2 Heterosubstituted pyridine derivatives as pde 4 inhibitors |
| 02/20/2002 | EP1180099A1 New compounds |
| 02/20/2002 | EP1180098A1 New compounds |
| 02/20/2002 | EP1180097A1 Mutual salt of amlodipine and atorvastatin |
| 02/20/2002 | EP1180094A1 Fused polycyclic amino acids as pharmaceutical agents |
| 02/20/2002 | EP1180058A1 Combinations of gaba analogs and tricyclic compounds to treat depression |
| 02/20/2002 | EP1180053A1 Remote and local controlled delivery of pharmaceutical compounds using electromagnetic energy |
| 02/20/2002 | EP1180042A1 Model membrane systems |
| 02/20/2002 | EP1180039A2 Factor for regulation of neurite growth |
| 02/20/2002 | EP1180038A2 Antifungal combination use |
| 02/20/2002 | EP1180035A1 NON-CALCEMIC, ANTIPROLIFERATIVE, TRANSCRIPTIONALLY ACTIVE SULFUR-CONTAINING ANALOGS OF 1$g(a), 25-DIHYDROXY VITAMIN D 3? |
| 02/20/2002 | EP1180034A1 Novel epidermal growth factor receptor-binding compounds for positron emission tomography |
| 02/20/2002 | EP1180033A2 Lamivudine containing pharmaceutical formulation |
| 02/20/2002 | EP1180032A2 Use of nicorandil in treatment of sexual dysfunctions or for enhancement of sexual functions |
| 02/20/2002 | EP1180031A1 Noscapine derivatives as adjuvant compositions and methods of use thereof |
| 02/20/2002 | EP1180030A1 Antibacterial compounds |
| 02/20/2002 | EP1180029A1 Bicyclic acyl guanidine sodium/proton exchange inhibitors and method |
| 02/20/2002 | EP1180028A1 Il-8 receptor antagonists |
| 02/20/2002 | EP1180027A1 Method for the prevention or reduction of cardiovascular events associated with coronary intervention |
| 02/20/2002 | EP1180026A2 Use of 15-deoxyspergualin for the treatment of hyperreactive inflammatory diseases and autoimmune diseases |
| 02/20/2002 | EP1180025A1 Il-8 receptor antagonists |
| 02/20/2002 | EP1180024A1 Z-styryl sulfone anticancer agents |
| 02/20/2002 | EP1180022A1 Process for preparing pharmaceutical bulk material having uniform dissolution |
| 02/20/2002 | EP1180021A1 Regimen and kit for amelioration of premature ejaculation |
| 02/20/2002 | EP1180018A1 Preparations for the application of anti-inflammatory agents |
| 02/20/2002 | EP1180017A1 Preparation for the application of anti-infective and/or anti-inflammatory agents |
| 02/20/2002 | EP1180014A2 Injectable anesthetic formulation |
| 02/20/2002 | EP1180012A1 Niacinamide compositions with reduced tack |
| 02/20/2002 | EP1180006A2 Compositions and methods for their preparation from lepidium |
| 02/20/2002 | EP1179984A1 Process and product for enhancing immune response in companion animal using a combination of antioxidants |
| 02/20/2002 | EP1142578A4 Method for producing an antitumoral agent and antitumoral agent thus obtained |
| 02/20/2002 | EP1041896B1 Fat blend |
| 02/20/2002 | EP1028707B1 Sustained release ophthalmic compositions containing water soluble medicaments |
| 02/20/2002 | EP0934079B1 Pharmaceutical composition containing lornoxicam and a disodic salt of edta |
| 02/20/2002 | EP0927171B1 Pyrazinones and triazinones and their derivatives thereof |
| 02/20/2002 | EP0917463B1 Tramadol multiple unit formulations |
| 02/20/2002 | EP0909182B1 Method for producing chlorins and bacteriochlorins containing polyether |
| 02/20/2002 | EP0893994B1 Diclofenac/gamma-cyclodextrin inclusion compounds |
| 02/20/2002 | EP0889898B1 Morpholinyl anthracycline derivatives |
| 02/20/2002 | EP0877024B1 Substituted 6-h-1,3,4-thiadiazine-2-amines, the use thereof as an aesthetising, cardiovascular and hypometabolic agents, and a pharmaceutical composition containing them |
| 02/20/2002 | EP0841922B1 1h-4(5)-substituted imidazole derivatives |
| 02/20/2002 | EP0783307B1 Use of 2,4-diamino pyrimidine 3-oxide or a salt thereof for treating collagen maturation and structuring disorders |